UK Graves' disease Market Industry Analysis by Top Key Players - Novartis International AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd

UK Graves' disease market is growing at a CAGR of around 4.1% during the forecast period. Grave's disease is one of the most prevalent autoimmune diseases across the UK. It is one of the leading causes of hyperthyroidism in the country. The disease is caused by a number of factors including the sedentary lifestyles, changing eating pattern, the prevalence of diabetes in the country are few of the key reasons which are expected to promote the demand of treatment and diagnostic services, which in turn increases the UK Graves' disease market. The prevalence of diabetes has increased significantly in the UK. According to The British Diabetic Association 2017, nearly 3.7 million people were diagnosed with diabetes. Amongst this 10 %, people have type-1 diabetes. As the prevalence of such disease increases in the country, the risk associated with Grave's disease is also increasing, thereby creating opportunities for the growth of the UK Graves' disease market during the forecast period.

Get Sample Copy of UK Graves' disease Market at: https://www.omrglobal.com/request-sample/uk-graves-disease-market

Key Players - Abbott Laboratories Inc., Allergan PLC, Eli Lilly and Co., GlaxoSmithKline PLC, Johnson & Johnson, Macleods Pharmaceuticals Ltd., Merck & Co. Inc., Mylan NV, Novartis International AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd.

Further, the prevalence of Grave's' disease is majorly amongst the age group of 19-54. According to Eurostat, the working-age population in the UK accounted for 64.4% of the overall population. The prevalence of Grave's disease also increases with changes in unhealthy eating patterns and smoking practices. It is observed that smoking is one of the key reasons which promote the prevalence of Grave's disease in the working-age population. The percentage of population smoking in the UK is majorly between the age group of 25-34. Owing to this, the prevalence of Grave's disease is expected to increase, thereby creating opportunities for the growth of the UK Graves' disease market.

For More Information, get A full report of UK Graves' disease Market is available at: https://www.omrglobal.com/industry-reports/uk-graves-disease-market

In addition, government initiative including the European Thyroid Association that has laid down numerous guidelines for the treatment of Grave's hyperthyroid is also augmenting the market growth. As technology advances, the adoption of the surgical process for the treatment of Grave's disease is expected to increase significantly in the coming years. Owing to this the proportion of patients treated from thyroidectomy is more from the Grave's disease. This is expected to promote the growth of the UK Graves' disease market in the near future.

Market Segmentation

Graves' Disease Market by Diagnosis

o Ultrasound
o Imaging Tests
o Radioactive Iodine Uptake
o Blood Sample

Graves' Disease Market by Treatment

o Anti- Thyroid Medication
o Radioactive Iodine Therapy
o Surgery

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/uk-graves-disease-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.